The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective

MLA

In-Ho Kim, and Hyo Jin Lee. “The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective.” Biomedicines, vol. 10, no. 2, Jan. 2022, p. 251. EBSCOhost, https://doi.org/10.3390/biomedicines10020251.

APA

In-Ho Kim, & Hyo Jin Lee. (2022). The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective. Biomedicines, 10(2), 251. https://doi.org/10.3390/biomedicines10020251

Chicago

In-Ho Kim, and Hyo Jin Lee. 2022. “The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective.” Biomedicines 10 (2): 251. doi:10.3390/biomedicines10020251.